InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,136.80
(
0.94%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.15
(
-0.01%
)
Bitcoin
64,453.78
(
-0.05%
)
Post# of 27359
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Katfish

Send PM Follow Ignore
Followers 79
Posts 24455
Boards Moderated 1
Alias Born 09/08/2000

Katfish

Member Level

Re: None

Wednesday, 03/03/2021 7:48:10 AM

Wednesday, March 03, 2021 7:48:10 AM

Post# of 27359
OVID - 2.96 Pre-market at 5.97/5.99


Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome

https://stockcharts.com/h-sc/ui?s=ovid
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up